Melexis NV

ENXTBR:MELE Lagerbericht

Marktkapitalisierung: €2.2b

Melexis Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Melexis wird ein jährliches Gewinn- und Umsatzwachstum von 5.5% bzw. 5.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 4.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 36.3% betragen.

Wichtige Informationen

5.5%

Wachstumsrate der Gewinne

4.3%

EPS-Wachstumsrate

Semiconductor Gewinnwachstum19.1%
Wachstumsrate der Einnahmen5.6%
Zukünftige Eigenkapitalrendite36.3%
Analystenabdeckung

Good

Zuletzt aktualisiert27 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

Aug 02
Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

Recent updates

These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well

Oct 31
These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Oct 11
Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Oct 01
Should You Think About Buying Melexis NV (EBR:MELE) Now?

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Aug 31
Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

There's Reason For Concern Over Melexis NV's (EBR:MELE) Price

Aug 19
There's Reason For Concern Over Melexis NV's (EBR:MELE) Price

Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

Aug 02
Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

A Look At The Fair Value Of Melexis NV (EBR:MELE)

Jul 04
A Look At The Fair Value Of Melexis NV (EBR:MELE)

Is There Now An Opportunity In Melexis NV (EBR:MELE)?

Jun 20
Is There Now An Opportunity In Melexis NV (EBR:MELE)?

Melexis (EBR:MELE) Knows How To Allocate Capital

Jun 07
Melexis (EBR:MELE) Knows How To Allocate Capital

Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly

May 22
Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly

Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment

May 08
Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment

Calculating The Fair Value Of Melexis NV (EBR:MELE)

Mar 27
Calculating The Fair Value Of Melexis NV (EBR:MELE)

At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Mar 14
At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

Feb 28
Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Feb 15
Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

Jan 02
Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Dec 09
What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Nov 27
Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Melexis (EBR:MELE) Knows How To Allocate Capital

Nov 15
Melexis (EBR:MELE) Knows How To Allocate Capital

Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Nov 03
Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Melexis' (EBR:MELE) Dividend Will Be €0.91

Oct 10
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Sep 26
Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Sep 17
Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Sep 02
Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Aug 19
Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Aug 05
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Might Become A Compounding Machine

Jul 13
Melexis (EBR:MELE) Might Become A Compounding Machine

Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?

Jun 29
Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?

Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)

Jun 02
Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)

At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Apr 11
At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case

Mar 27
With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case

Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Jan 09
Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Dec 24
Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 24
Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Oct 18
Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Oct 04
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Sep 20
Melexis' (EBR:MELE) Dividend Will Be €0.91

We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease

Sep 19
We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease

Melexis' (EBR:MELE) Dividend Will Be €0.91

Sep 05
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Aug 22
Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Melexis (EBR:MELE) Will Pay A Dividend Of €0.91

Aug 04
Melexis (EBR:MELE) Will Pay A Dividend Of €0.91

Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?

Jul 11
Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?

Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Jun 27
Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?

Jun 13
Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Mar 01
Should You Think About Buying Melexis NV (EBR:MELE) Now?

Calculating The Fair Value Of Melexis NV (EBR:MELE)

Feb 14
Calculating The Fair Value Of Melexis NV (EBR:MELE)

Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Dec 06
Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Nov 18
Should You Think About Buying Melexis NV (EBR:MELE) Now?

Gewinn- und Umsatzwachstumsprognosen

ENXTBR:MELE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20261,04420516422411
12/31/202593216614620111
12/31/20249411821682379
9/30/2024986203101169N/A
6/30/202498720970153N/A
3/31/2024978211-913N/A
12/31/2023964209-923N/A
9/30/2023938212-747N/A
6/30/2023909204-2142N/A
3/31/2023881199132184N/A
12/31/2022836197148188N/A
9/30/2022779178158194N/A
6/30/2022722166124161N/A
3/31/2022672152105140N/A
12/31/2021644131103142N/A
9/30/202162512295132N/A
6/30/202158410092123N/A
3/31/20215257680109N/A
12/31/2020508697196N/A
9/30/2020487617295N/A
6/30/20204896181104N/A
3/31/20205096775101N/A
12/31/2019487606894N/A
9/30/20195017367105N/A
6/30/2019525884596N/A
3/31/20195471013598N/A
12/31/201856911523100N/A
9/30/2018560114578N/A
6/30/2018541112N/A89N/A
3/31/2018527114N/A106N/A
12/31/2017512111N/A113N/A
9/30/2017499109N/A116N/A
6/30/2017486107N/A96N/A
3/31/201747099N/A108N/A
12/31/201645696N/A108N/A
9/30/201643993N/A116N/A
6/30/201642693N/A134N/A
3/31/201641595N/A127N/A
12/31/201540099N/A115N/A
9/30/201538697N/A109N/A
6/30/201537197N/A103N/A
3/31/201535193N/A97N/A
12/31/201433285N/A95N/A
9/30/201431981N/A95N/A
6/30/201430471N/A84N/A
3/31/201428963N/A80N/A
12/31/201327555N/A71N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: MELEDas prognostizierte Gewinnwachstum (5.5% pro Jahr) liegt über der Sparquote (1.4%).

Ertrag vs. Markt: MELEDie Erträge des Unternehmens (5.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Belgian (19.8% pro Jahr).

Hohe Wachstumserträge: MELEDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: MELEDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Belgian (7.1% pro Jahr).

Hohe Wachstumseinnahmen: MELEDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: MELEDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (36.3%)

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y